Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis

计划入组 2,881 人 · 首次发布于 2022 年 11 月 14 日

Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient

计划入组 10 人 · 首次发布于 2026 年 3 月 4 日

A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition

计划入组 15 人 · 首次发布于 2011 年 6 月 28 日

DW MSC ( Daewoong Pharmaceutical)

hES-MSC

Clostridium botulinum Toxin (Daewoong Pharmaceutical)

DAEWOONG BIO INC.

South Korea

PT. DAEWOONG INFION

Indonesia

Daewoong America, Inc.

United States

Daewoong Pharmaceutical Receives IND Approval for Microneedle Growth Hormone Patch

Daewoong Pharmaceutical's SGLT-2 Inhibitor Envlo Approved in Ecuador

Daewoong Pharmaceutical Enters Biosimilar Market with Former Celltrion Executive Leading New Division